Summary of Significant Accounting Policies (Details) - Schedule of Revenue - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Schedule of Revenue [Line Items]
Total revenue		$ 709	$ 1,222
National Institute of Health - grant [Member]
Schedule of Revenue [Line Items]
Total revenue		41	164
Clinical trial revenue [Member]
Schedule of Revenue [Line Items]
Total revenue		668	940
MSCRF – TEDCO - grants [Member]
Schedule of Revenue [Line Items]
Total revenue	[1]		$ 118

[1] Maryland Stem Cell Research Fund (MSCRF) - Maryland Technology Development Corporation (TEDCO)